Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Corvus Pharmaceuticals Inc buy Cantor Fitzgerald

Start price
€1.67
01.04.24 / 50%
Target price
-
01.04.25
Performance (%)
-13.50%
Price
€1.44
02.05.24
Summary
This prediction is currently active. The price of Corvus Pharmaceuticals Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.50%. This prediction currently runs until 01.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Corvus Pharmaceuticals Inc 5.045% 5.045%
iShares Core DAX® 0.000% -2.064%
iShares Nasdaq 100 0.626% -2.884%
iShares Nikkei 225® 1.568% -5.892%
iShares S&P 500 0.334% -2.281%

Comments by Cantor_Fitzgerald for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat

Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.51
07.09.23
€3.74
07.09.24
-4.11%
02.05.24